Chuck Royce Acorda Therapeutics Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$66.1

Avg closing price
Price range
Chuck Royce Portfolio Stock Details (ACOR)

9 Chuck Royce Acorda Therapeutics Trades

Chuck Royce started to build up the position in Acorda Therapeutics in Q1 2018 and continued to invest until Q3 2019. Since then they sold 210 shares. The investor completely sold their stake between Q1 2020 and Q1 2021.

Avg closing price
Price range
Sold -107 shares Q1 2021
Avg closing price $6.14
Price range $3.80 - $8.04
Sold 28.2% shares (-42 shares) Q4 2020
Avg closing price $4.60
Price range $3.12 - $6.60
Sold 28.9% shares (-61 shares) Q1 2020
Avg closing price $9.84
Price range $4.66 - $14.88
Increased shares by 6.0% (+12 shares) Q3 2019
Avg closing price $27.18
Price range $14.34 - $46.14
Increased shares by 900.0% (+180 shares) Q2 2019
Avg closing price $61.44
Price range $41.58 - $80.46
Increased shares by 53.8% (+7 shares) Q1 2019
Avg closing price $90.08
Price range $77.58 - $104.82
Increased shares by 225.0% (+9 shares) Q3 2018
Avg closing price $154.78
Price range $103.50 - $183.30
Increased shares by 33.3% (+1 shares) Q2 2018
Avg closing price $153.10
Price range $133.80 - $195.60
New holding (+3 shares) Q1 2018
Avg closing price $149.71
Price range $126.30 - $166.80
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.